Inside information proposed a share listing plan
Filed with HKEX · Stock code 7666 · · 2 pages · English
Summary by 6ix AI
Metis TechBio Co., Ltd. has announced a proposed plan for an A share listing to enhance its business development and competitive strength. The company intends to issue RMB-denominated ordinary shares and has engaged a pre-listing tutoring institution for this purpose. Shareholders are cautioned that the proposed listing is subject to further approvals and may or may not proceed. This announcement serves as a notification and does not constitute an invitation to acquire shares.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Metis TechBio Co., Ltd. on 6ix
Earlier from Metis TechBio
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement Metis TechBio entered strategic collaboration with lilly to advance next-generation tissue-specific LNP delivery technologies
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim Report
- METiS TechBio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager
Later from Metis TechBio
All Metis TechBio news releasesFollow Metis TechBio into a list and get an email when it puts out news.
Follow Metis TechBio